DERM — Journey Medical Cashflow Statement
0.000.00%
- $109.27m
- $102.90m
- $79.18m
- 73
- 27
- 81
- 63
Annual cashflow statement for Journey Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 3.63 | 5.28 | -44 | -29.6 | -3.85 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.595 | 0.9 | 23.1 | 5.63 | 6.98 |
Unusual Items | |||||
Purchased R&D | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 3.46 | -2.23 | 14.7 | 6.19 | -1.66 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Cash from Operating Activities | 9.02 | 5.13 | -2.18 | -13.5 | 5.24 |
Capital Expenditures | -2.4 | -1.2 | -10 | -20 | -5 |
Purchase / Acquisition of Intangibles | |||||
Cash from Investing Activities | -2.4 | -1.2 | -10 | -20 | -5 |
Financing Cash Flow Items | — | — | -3.55 | -0.585 | 4.02 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -3.55 | -0.487 | 53 | 16.5 | -4.8 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 3.07 | 3.44 | 40.8 | -17.1 | -4.56 |